These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1012 related articles for article (PubMed ID: 32226518)

  • 1. Expression Status And Prognostic Value Of M6A-associated Genes in Gastric Cancer.
    Guan K; Liu X; Li J; Ding Y; Li J; Cui G; Cui X; Sun R
    J Cancer; 2020; 11(10):3027-3040. PubMed ID: 32226518
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk Score Prediction Model of Prognosis in GC Patients by Age and Gender Combined With m6A Modification Genes FTO and RBM15.
    Yue L; Zhang R; Chen S; Duan G
    Front Cell Dev Biol; 2022; 10():710708. PubMed ID: 35433701
    [No Abstract]   [Full Text] [Related]  

  • 3. N6-methyladenosine-related Genomic Targets are Altered in Breast Cancer Tissue and Associated with Poor Survival.
    Liu L; Liu X; Dong Z; Li J; Yu Y; Chen X; Ren F; Cui G; Sun R
    J Cancer; 2019; 10(22):5447-5459. PubMed ID: 31632489
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer.
    Li Y; Zheng D; Wang F; Xu Y; Yu H; Zhang H
    Dig Dis Sci; 2019 Jun; 64(6):1503-1513. PubMed ID: 30637548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
    Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C
    BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and Predictive Value of m6A "Eraser" Related Gene Signature in Gastric Cancer.
    Xu X; Zhou E; Zheng J; Zhang C; Zou Y; Lin J; Yu J
    Front Oncol; 2021; 11():631803. PubMed ID: 33718213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Validation of an m6A Modification of JAK-STAT Signaling Pathway-Related Prognostic Prediction Model in Gastric Cancer.
    Jiang F; Chen X; Shen Y; Shen X
    Front Genet; 2022; 13():891744. PubMed ID: 35928449
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients.
    Wang JM; Li X; Yang P; Geng WB; Wang XY
    BMC Gastroenterol; 2022 Feb; 22(1):76. PubMed ID: 35189810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N
    Wang D; Qu X; Lu W; Wang Y; Jin Y; Hou K; Yang B; Li C; Qi J; Xiao J; Che X; Liu Y
    Front Oncol; 2021; 11():681280. PubMed ID: 34277426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.
    Jing JJ; Zhao X; Li H; Sun LP; Yuan Y
    Future Oncol; 2021 Jul; 17(20):2605-2620. PubMed ID: 33878934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTO is Associated with Patient Prognosis and Immune Infiltrates in Gastric Cancer and Regulates TGF-β Expression.
    Lai H; Hu N; Zhang M; Jiang W; Han Y; Mao C; Zhou K; Zhang J; Hong Y; Wu F
    Comb Chem High Throughput Screen; 2024 Jun; ():. PubMed ID: 38879772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a five m6A-relevant mRNAs signature and risk score for the prognostication of gastric cancer.
    Yin L; Feng S; Sun Y; Jiang Y; Tang C; Sun D
    J Gastrointest Oncol; 2022 Oct; 13(5):2234-2248. PubMed ID: 36388685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma.
    Li J; Rao B; Yang J; Liu L; Huang M; Liu X; Cui G; Li C; Han Q; Yang H; Cui X; Sun R
    Front Oncol; 2020; 10():769. PubMed ID: 32582536
    [No Abstract]   [Full Text] [Related]  

  • 14. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
    J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
    Zhao J; Lin X; Zhuang J; He F
    Front Genet; 2021; 12():714697. PubMed ID: 34777460
    [No Abstract]   [Full Text] [Related]  

  • 16. Estimating the prognosis of esophageal squamous cell carcinoma based on The Cancer Genome Atlas (TCGA) of m6A methylation-associated genes.
    Pu Y; Lu X; Yang X; Yang Y; Wang D; Li M; Guan W; Xu M
    J Gastrointest Oncol; 2022 Feb; 13(1):1-12. PubMed ID: 35284129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network analysis of miRNA targeting m6A-related genes in patients with esophageal cancer.
    Li L; Xie R; Wei Q
    PeerJ; 2021; 9():e11893. PubMed ID: 34395102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Five N6-Methylandenosine-Related ncRNA Signatures to Predict the Overall Survival of Patients with Gastric Cancer.
    Yue Q; Zhang Y; Bai J; Duan X; Wang H
    Dis Markers; 2022; 2022():7765900. PubMed ID: 35774851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia.
    Fu C; Kou R; Meng J; Jiang D; Zhong R; Dong M
    BMC Med Genomics; 2023 Aug; 16(1):191. PubMed ID: 37596597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
    Zhang Y; Liu X; Liu L; Li J; Hu Q; Sun R
    Med Sci Monit; 2020 Feb; 26():e919644. PubMed ID: 32086933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.